Natural Bioactive Compounds in the Management of Type 2 Diabetes and Metabolic (Dysfunction)-Associated Steatotic Liver Disease
Pharmaceuticals · 19.02.2025 · 18 (2) · 279
DOI: 10.3390/ph18020279 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 19.02.2025. Verfasst von Daniela Ciobârcă und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department 2, Faculty of Nursing and Health Sciences, "Iuliu Hatieganu" University of Medicine and Pharmacy, 23 Gheorghe Marinescu Street, 400337 Clu…. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 261 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Type 2 diabetes (T2D) and metabolic (dysfunction)-associated steatotic liver disease (MASLD) affect a growing number of individuals worldwide. T2D and MASLD often coexist and substantially elevate the risk of adverse hepatic and cardiovascular clinical outcomes. Several common pathogenetic mechanisms are responsible for T2D and MASLD onset and progression, including insulin resistance, oxidative stress, and low-grade inflammation, among others. The latter can also be induced by gut microbiota and its derived metabolites. Natural bioactive compounds (NBCs) have been reported for their therapeutic potential in both T2D and MASLD. A large amount of evidence obtained from clinical trials suggests that compounds like berberine, curcumin, soluble fibers, and omega-3 fatty acids exhibit significant hypoglycemic, hypolipidemic, and hepatoprotective activity in humans and may be employed as adjunct therapy in T2D and MASLD management. In this review, the role of the most studied NBCs in the management of T2D and MASLD is discussed, emphasizing recent clinical evidence supporting these compounds’ efficacy and safety. Also, prebiotics that act against metabolic dysfunction by modulating gut microbiota are evaluated.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department 2, Faculty of Nursing and Health Sciences, "Iuliu Hatieganu" University of Medicine and Pharmacy, 23 Gheorghe Marinescu Street, 400337 Cluj-Napoca, Romania.
- Department of Pathophysiology, Faculty of Medicine, "Iuliu Hatieganu" University of Medicine and Pharmacy, 2-4 Victor Babes Street, 400012 Cluj-Napoca, Romania.
- Department of Bromatology, Hygiene, Nutrition, Faculty of Pharmacy, "Iuliu Hatieganu" University of Medicine and Pharmacy, 6 Louis Pasteur Street, 400349 Cluj-Napoca, Romania.
- Academy of Romanian Scientists (AOSR), 3 Ilfov Street, 050044 Bucharest, Romania.
ORCID-Profile: Daniela Ciobârcă, Roxana Banc, Doina Miere, Lorena Filip
Zitieren
APA
Ciobârcă, D., Cătoi, A. F., Gavrilaș, L., Banc, R., Miere, D., & Filip, L. (2025). Natural Bioactive Compounds in the Management of Type 2 Diabetes and Metabolic (Dysfunction)-Associated Steatotic Liver Disease. Pharmaceuticals, 18(2), 279. https://doi.org/10.3390/ph18020279
Vancouver
Ciobârcă D, Cătoi AF, Gavrilaș L, Banc R, Miere D, Filip L. Natural Bioactive Compounds in the Management of Type 2 Diabetes and Metabolic (Dysfunction)-Associated Steatotic Liver Disease. Pharmaceuticals. 2025;18(2):279. doi:10.3390/ph18020279
BibTeX
@article{Ciobrc2025,
author = {Ciobârcă, Daniela and Cătoi, Adriana Florinela and Gavrilaș, Laura and Banc, Roxana and Miere, Doina and Filip, Lorena},
title = {Natural Bioactive Compounds in the Management of Type 2 Diabetes and Metabolic (Dysfunction)-Associated Steatotic Liver Disease},
journal = {Pharmaceuticals},
year = {2025},
volume = {18},
number = {2},
pages = {279},
doi = {10.3390/ph18020279}
}
EUVIMED